Medical Equipment

Transfection Reagents And Equipment Market Outlook 2026–2030 Exploring New Business Opportunities

March 17, 2026March 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Transfection Reagents And Equipment Market During 2026–2030?

The market for transfection reagents and equipment has experienced rapid expansion in recent years. It is projected to grow from $1.74 billion in 2025 to $1.93 billion in 2026, at a compound annual growth rate (CAGR) of 11.2%. This historical growth can be attributed to factors such as the expansion of molecular biology research activities, the increasing use of cell-based assays, advancements in recombinant protein production, the rise in academic and industrial genomics research, and the availability of advanced transfection chemistries.

The transfection reagents and equipment market is projected to experience swift expansion over the coming years. This market is set to reach $2.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this growth during the forecast period include the rising adoption of CRISPR and gene therapy research, a surge in demand for scalable transfection platforms, the expanding development of biopharmaceutical pipelines, increased investment in precision medicine, and the growing automation within life science laboratories. Key trends anticipated during this period encompass the wider embrace of high-efficiency transfection reagents, an escalating demand for gene editing-compatible delivery systems, the increasing utilization of non-viral transfection techniques, the proliferation of automated transfection instruments, and a heightened emphasis on cell-type specific transfection solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp

Which Major Factors Are Driving The Expansion Of The Transfection Reagents And Equipment Market?

The increasing global prevalence of cancer patients is anticipated to drive the expansion of the transfection reagents and equipment market in the future. Cancer refers to a collection of illnesses characterized by the abnormal and unchecked proliferation of cells. In cancer research, transfection reagents are frequently employed to insert exogenous genetic material, like plasmid DNA or RNA molecules, enabling scientists to explore different facets of cancer biology, including gene expression analyses, gene silencing, drug discovery, and target identification. As an illustration, in July 2024, Cancer Research UK, a cancer charity based in the United Kingdom, published projections indicating that cancer incidence rates in the United Kingdom are forecasted to rise for the majority of types between the periods 2023-2025 and 2038-2040, showing increases from less than 1% for breast cancer up to 50% for eye cancer; conversely, a minority of cancers are expected to decline, with reductions from 2% for lung cancer to 27% for mesothelioma. Consequently, the growing global count of cancer patients is a key factor propelling the expansion of the transfection reagents and equipment market.

How Are The Various Segments Of The Transfection Reagents And Equipment Market Categorized?

The transfection reagents and equipment market covered in this report is segmented –

1) By Product: Instruments, Reagent And Kits

2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules

3) By End User: Biopharma, Contract Research Organizations (CROs), Academia

Subsegments:

1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems

2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits

What Trends Are Affecting The Expansion Of The Transfection Reagents And Equipment Market?

Companies operating within the transfection reagents and equipment market are increasingly concentrating on developing advanced innovations, such as GMP-grade AAV transfection reagents, to enhance viral vector production efficiency and support the large-scale manufacturing of gene therapies. A GMP-grade AAV transfection reagent represents a regulatory-compliant chemical mixture specifically designed to facilitate high-efficiency genetic material delivery into suspension cell cultures, enabling the scalable manufacturing of recombinant adeno-associated virus vectors. For instance, in July 2025, Yeasen Biotechnology, a China-based biotechnology manufacturer, secured U.S. Food and Drug Administration Drug Master File acceptance for its UltraAAV PEI Transfection Reagent—GMP grade. This particular reagent exhibits substantially higher viral titers and notably improved full capsid ratios across various adeno-associated virus serotypes, thereby delivering superior performance compared to standard formulations. Furthermore, it improves manufacturing efficiency by achieving comparable vector yields with reduced reagent usage, all while complying with strict regulatory and quality standards essential for both clinical and commercial gene therapy production.

Which Major Firms Influence Developments In The Transfection Reagents And Equipment Market?

Major companies operating in the transfection reagents and equipment market are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc.

Read the full transfection reagents and equipment market report here:

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Which Region Currently Holds The Largest Share Of The Transfection Reagents And Equipment Market?

North America was the largest region in the transfection reagents and equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Transfection Reagents And Equipment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10780&type=smp

Browse Through More Reports Similar to the Global Transfection Reagents And Equipment Market 2026, By The Business Research Company

Biotechnology Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report

Sterilization Equipment And Disinfectants Market 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Sequencing Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/sequencing-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795